RB1
RB1 (RB transcriptional corepressor 1), also known as retinoblastoma-associated protein, RB, PPP1R130 and OSRC, is a negative regulator of the cell cycle and was the first tumour suppressor gene to be identified. It also helps maintain chromatin structure. Browse Assay Genie's current range of RB1 research reagents below, or read on for the biology behind the target.
RB1 is a negative regulator of the cell cycle. Its active, hypophosphorylated form binds the transcription factor E2F1, and this interaction underlies its role in restraining cell cycle progression. RB1 also stabilises constitutive heterochromatin, contributing to the maintenance of overall chromatin structure. The protein is annotated in both the nucleus and the cytoplasm.
The RB1 gene encodes retinoblastoma-associated protein, a member of the retinoblastoma protein (RB) family. Researchers working with the RB1 protein often study its phosphorylation state, since only the hypophosphorylated form is active in binding E2F1. Orthologues of the gene are present in mouse and rat, both named Rb1, which allows the pathway to be studied in rodent models.
RB1 was the first tumour suppressor gene found. Its former names, retinoblastoma 1 and osteosarcoma, reflect the diseases linked to it: defects in the RB1 gene are a cause of the childhood cancer retinoblastoma, as well as bladder cancer and osteogenic sarcoma. In viral infection, SV40 large T antigen, HPV E7 protein and adenovirus E1A protein interact with RB1 and induce disassembly of the RB1-E2F1 complex, which disrupts RB1 activity.
RB1 is a negative regulator of the cell cycle, and its hypophosphorylated form binds E2F1, making it central to studies of proliferation control.
Defects in RB1 cause retinoblastoma and are linked to bladder cancer and osteogenic sarcoma, making it a key tumour suppressor in oncology research.
RB1 stabilises constitutive heterochromatin to maintain overall chromatin structure, linking this tumour suppressor to chromatin biology.
SV40 large T antigen, HPV E7 and adenovirus E1A disrupt the RB1-E2F1 complex, providing a model for viral interference with host cell cycle control.
RB1 is a negative regulator of the cell cycle. Its active, hypophosphorylated form binds the transcription factor E2F1. It also stabilises constitutive heterochromatin to maintain overall chromatin structure. It was the first tumour suppressor gene to be discovered.
The HGNC name is RB transcriptional corepressor 1, and UniProt lists retinoblastoma-associated protein. Aliases include RB, PPP1R130 and OSRC. Earlier gene names were retinoblastoma 1 and osteosarcoma, the latter reflecting its link to osteogenic sarcoma.
Defects in RB1 cause the childhood cancer retinoblastoma and are linked to bladder cancer and osteogenic sarcoma. Mouse and rat each have an Rb1 ortholog. Check the datasheet of any product for its validated reactivity.
Other retinoblastoma-related proteins and RB-binding or RB-named targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P06400; product specifications from Assay Genie datasheets.